Eglisau, Switzerland

Eliane Fischer

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Eliane Fischer: Innovator in Enzymatic Functionalization

Introduction

Eliane Fischer is a prominent inventor based in Eglisau, Switzerland. She has made significant contributions to the field of biochemistry, particularly in the area of enzymatic conjugation of antibodies and polypeptides. With a total of seven patents to her name, her work has the potential to impact pharmaceutical compositions and treatment methods for various diseases.

Latest Patents

Eliane Fischer's latest patents include innovative methods for the functionalization of immunoglobulins. The first patent focuses on the enzymatic conjugation of antibodies, detailing methods that involve linking reagents and functionalized antibodies. This patent aims to enhance the efficacy of pharmaceutical compositions and improve methods of treating diseases and conditions. The second patent similarly addresses the enzymatic conjugation of polypeptides, emphasizing the functionalization of immunoglobulins with drugs. Both patents highlight her commitment to advancing therapeutic techniques in the medical field.

Career Highlights

Throughout her career, Eliane Fischer has worked with notable organizations such as Innate Pharma and the Paul Scherrer Institut. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Eliane has collaborated with esteemed colleagues, including Patrick Dennler and Delphine Bregeon. These partnerships have further enriched her research and development efforts, fostering innovation in her projects.

Conclusion

Eliane Fischer stands out as a key figure in the realm of enzymatic functionalization, with her patents paving the way for advancements in medical treatments. Her dedication to innovation and collaboration continues to drive her success in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…